Vertex Pharmaceuticals Inc. buy Piper Sandler
Start price
02.08.24
/
50%
€451.85
Target price
02.08.25
€489.95
Performance (%)
-11.64%
End price
03.08.25
€399.25
Summary
This prediction ended on 03.08.25 with a price of €399.25. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.64%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 10.633% | 10.633% | 42.147% |
| iShares Core DAX® | 0,18 % | 5,07 % | 8,98 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % | 26,44 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % | 47,89 % |
| iShares S&P 500 | -0,17 % | 0,90 % | 22,97 % |
Comments by Piper_Sandler for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Piper Sandler from $500.00 to $535.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Piper_Sandler for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€425.65
27.01.25
27.01.25
€507.36
27.01.26
27.01.26
-6.80%
28.01.26
28.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.70
07.05.24
07.05.24
€423.03
07.05.25
07.05.25
2.92%
08.05.25
08.05.25